These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8573174

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
    Bao G, Gohlke P, Unger T.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
    Marin-Castaño ME, Schanstra JP, Neau E, Praddaude F, Pecher C, Ader JL, Girolami JP, Bascands JL.
    Circulation; 2002 Feb 05; 105(5):627-32. PubMed ID: 11827930
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
    Sasamura H, Shimizu-Hirota R, Nakaya H, Saruta T.
    Hypertens Res; 2001 Mar 05; 24(2):165-72. PubMed ID: 11325076
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula rats.
    Nishikimi T, Tani T, Ohmura T, Yamagishi H, Yanagi S, Yoshiyama M, Toda I, Teragaki M, Akioka K, Takeuchi K.
    Jpn Circ J; 1995 Nov 05; 59(11):754-61. PubMed ID: 8747765
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term effects of angiotensin-converting enzyme inhibition on renal medullary neutral lipid in spontaneously hypertensive rats.
    O'Sullivan JB, Harrap SB.
    Hypertension; 1999 May 05; 33(5):1214-7. PubMed ID: 10334814
    [Abstract] [Full Text] [Related]

  • 32. Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats.
    Sugimoto K, Fujimura A.
    Jpn J Pharmacol; 1998 Apr 05; 76(4):431-4. PubMed ID: 9623722
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
    Häckl LP, Cuttle G, Dovichi SS, Lima-Landman MT, Nicolau M.
    Pharmacology; 2002 Aug 05; 65(4):182-6. PubMed ID: 12174832
    [Abstract] [Full Text] [Related]

  • 36. Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.
    Erlich Y, Rosenthal T.
    J Cardiovasc Pharmacol; 1998 Apr 05; 31(4):581-4. PubMed ID: 9554808
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT1 /bradykinin B2 receptor heterodimerization.
    Anton EL, Fernandes D, Assreuy J, da Silva-Santos JE.
    Br J Pharmacol; 2019 Jul 05; 176(14):2608-2626. PubMed ID: 30945263
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.